Cardio Diagnostics Holdings, Inc. (CDIO): Total Liabilities
$793.1K
As of 2025-12-31
$499.8K
As of 2026-06-30
-25.9%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $793.1K | -25.0% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $1.06M | -29.7% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $1.50M | -22.8% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $1.95M | n/m | 2024-04-01, Balance as of period end |
| 2021-12-31 | $33.9K | n/a | 2023-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | 2025-12-31 | $793.1K | -25.0% |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $55.82M | +23.1% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $42.49M | +19.7% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $57.22M | +20.8% |
| Biomerica Inc (BMRA) | 2026-05-31 | $4.13M | +124.4% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $87.8K | -94.9% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $12.39M | +53.8% |
| Immucell Corp (ICCC) | 2025-12-31 | $15.48M | -12.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $34.81M | -4.3% |
Compare CDIO, CLDX, VNRX, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗